 | ||
   | ||
Email
Glossary |
|
CV Genotype 3B- in continuation to my q on 26- Nov-10 Feb 11, 2011 26.Nov.10 Old Query: I have been diagnosed incidentally for HEP C genotype 3b and my viral load is 407302 copies/ mL in the PCR Test (gene amplification technique (ROCHE Cobas- Amplicor HCV version 2.0.)) Is this a high load. Currently being treated with Ribavarin(600mg twice a day) and Pegasys (once a week). 7.Feb.11 New Query: Touch Wood, as advised by you regarding my mail dated 26. Nov. 2010, my 4th week PCR was <15UL/ ml but said positive. (1) What does this mean? I am very confused and very anxious to receive your valuable advice in this regard. |
||||||||
 |
||||||||||
|
||||||||||
 |
| Response from Dr. McGovern
 It appears that you have achieved a rapid virologic response defined as <50 copies of virus at the 4 week time point. You have an excellent chance of cure. You should discuss the length of treatment with your physician. If you are doing well and tolerating the therapy, I would favor 6 months. If not, and you are having many side effects, you could consider a shorter time period of 4 months. If you have advanced liver disease (eg, cirrhosis) I would go for 6 months of treatment. Usually we treat genotype 3 with 400 mg twice daily of ribavirin. Your physician may have a reason as to why he/she is giving a higher dose. I would inquire.... Best regards.... | ||||||||
 Get Email Notifications When This Forum Updates or Subscribe With RSS
|
||||||||||
|
||||||||||
Q&A TERMS OF USE
This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.
Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.
Review our complete terms of use and copyright notice.
